•
Jun 30, 2012

EyePoint Pharmaceuticals Q4 2012 Earnings Report

Total Revenue
$700K
Previous year: $3.72M
-81.2%
EPS
-$1.1
Previous year: -$4.4
-75.0%
Gross Profit
-$711K
Previous year: $3.72M
-119.1%
Cash and Equivalents
$4.63M
Previous year: $12.9M
-64.2%
Free Cash Flow
-$1.84M
Previous year: $1.18M
-256.3%
Total Assets
$20.6M
Previous year: $47.1M
-56.3%

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals